Sector: MedicalQLT Inc. (NASDAQ: QLTI)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 119 |
Technical : | 35 |
Performance : | 229 |
Overall: | 114 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 117 |
Technical : | 179 |
Performance : | 248 |
Overall: | 216 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 122 |
Technical : | 140 |
Performance : | 259 |
Overall: | 203 |
Number of Stocks: | 306 |
Headlines
- QLT announces Toronto Stock Exchange approval of share repurchase program
Oct 28, 2009 05:05 PM | QLTI
- QLT Announces Share Repurchase Program
Oct 27, 2009 07:14 AM | NVS, QLTI
- NB Public Equity K/S Announces Sale of Shares of QLT, Inc.
Oct 22, 2009 05:05 PM | QLTI
- QLT restructures Visudyne(R) agreement
Oct 19, 2009 06:30 AM | NVS, QLTI
- Dr. Stockpick Announces Daily Stock Watch - QLTI, IMCI, PTN
Oct 02, 2009 09:35 AM | PTN, QLTI
- QLT announces sale of QLT USA, Inc. for up to US$230 million
Oct 01, 2009 05:10 PM | QLTI
- Mutual Funds Are For Suckers
Jul 17, 2009 12:57 PM | QLTI
- QLT Inc. announces agreement for sale of real estate and Geron shares recover after drop on study delay
May 16, 2008 09:29 AM | OMRI, QLTI
- Aida Announces Completion of Anti-Cancer Drug Phase Two Testing and QLT Board Authorizes Exploration of Strategic Alternatives to Enhance Near- to Mid-term Shareholder Value
Nov 29, 2007 11:58 AM | ARIA, GILD, QLTI
- Gilead Paid Lobbyist $150,000 in 2007 and QLT Acquires Eading Edge Ocular Drug Delivery System from ForSight Labs
Oct 10, 2007 09:28 AM | ACAD, GILD, QLTI
- QLT Announces Receipt of a CDN$45.3 Million Tax Refund
Sep 08, 2009 07:51 AM | QLTI
- QLT Announces Second Quarter Results for 2009
Jul 28, 2009 07:58 AM | NVS, QLTI
- QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System
Jul 28, 2009 07:30 AM | QLTI
- Zymeworks Closes $3.5 Million Round of Financing and Announces Changes to Its Board of Directors
Jun 23, 2009 09:11 AM | QLTI
- QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Jun 15, 2009 07:00 AM | QLTI
- QLT announces positive results from the evaluation of Visudyne(R) combination therapy
Jun 02, 2009 07:01 AM | QLTI
- QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court
May 21, 2009 07:42 PM | QLTI
- QLT Announces First Quarter Results for 2009
Apr 28, 2009 11:56 AM | NVS, QLTI
- QLT Names Kathryn Falberg to the Board of Directors
Mar 26, 2009 09:54 AM | AMGN, HGSI, NVS, QLTI
- QLT names Kathryn Falberg to the board of directors
Mar 26, 2009 07:30 AM | QLTI
- Form 4 Nelson Cameron For: Nov 06 (10K)
Nov 10, 2009 08:39 PM
- Form 4 QLT INC/BC For: Nov 03 Filed by: CLARKE C BOYD (10K)
Nov 05, 2009 07:25 PM
- Form 4 BUTCHOFSKY ROBERT For: Nov 03 (10K)
Nov 04, 2009 08:46 PM
- Form 4 QLT INC/BC For: Oct 21 Filed by: Schonharting Florian (10K)
Oct 23, 2009 05:25 PM
- Form 4/A Hao Yong For: Mar 11 (10K)
May 26, 2009 10:20 PM
- Form 4 Massey Ian J For: May 14 (10K)
May 15, 2009 09:30 PM
- Form 4 CARTER BRUCE L A For: May 14 (10K)
May 15, 2009 09:23 PM
- Form 4 CROSSGROVE PETER A For: May 13 (10K)
May 15, 2009 09:20 PM
- Form 4 QLT INC/BC For: May 12 Filed by: CLARKE C BOYD (10K)
May 13, 2009 07:14 PM
- Form 4 WOOD JACK For: May 05 (10K)
May 07, 2009 07:09 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
QLTI
|
Compare to S&P
|
| YTD |
53.11 %
|
26.72 %
|
| 4 Weeks |
5.13 %
|
3.99 %
|
| 12 Weeks |
-12.97 %
|
-17.95 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -37.50 %
|
|
EPS Growth in Last Year: 25.00 %
|
|
Sales Growth in Last Quarter: -73.38 %
|
|
Sales Growth in Last Quarter: -19.17 %
|
|
